Mengis Capital Management, Inc. Novartis Ag Transaction History
Mengis Capital Management, Inc.
- $640 Million
- Q1 2024
A detailed history of Mengis Capital Management, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Mengis Capital Management, Inc. holds 83,793 shares of NVS stock, worth $8.92 Million. This represents 1.27% of its overall portfolio holdings.
Number of Shares
83,793
Previous 81,943
2.26%
Holding current value
$8.92 Million
Previous $7.93 Million
2.26%
% of portfolio
1.27%
Previous 1.38%
Shares
26 transactions
Others Institutions Holding NVS
# of Institutions
1,343Shares Held
140MCall Options Held
1.15MPut Options Held
866K-
Primecap Management CO Pasadena, CA12.4MShares$1.32 Billion0.91% of portfolio
-
Dodge & Cox San Francisco, CA12.4MShares$1.32 Billion0.73% of portfolio
-
Morgan Stanley New York, NY7.26MShares$773 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX6.02MShares$641 Million0.16% of portfolio
-
Loomis Sayles & CO L P5.92MShares$630 Million0.81% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $229B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...